Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Avatrombopag

An oral thrombopoietin receptor agonist that stimulates platelet production; approved in the United States in May 2018 for adults with chronic liver disease and low platelets who are scheduled for a procedure. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It mimics thrombopoietin, the hormone that controls platelet production and is made mainly by the liver: this is why platelets often fall in chronic liver disease.

AvatrombopagGo to the active ingredient →
AvatrombopagActive ingredientAvatrombopagCat. No. P-A221-001CAS 570406-98-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.